Background We previously demonstrated that hsa-miR-520d-5p can convert cancer cells into

Background We previously demonstrated that hsa-miR-520d-5p can convert cancer cells into induced pluripotent stem cells (iPSCs) or mesenchymal stem cells (MSCs) via a demethylation process and p53 upregulation in vivo. tumors. In mice whose tumors disappeared the existence of human genomic material at the injection site was examined by quantitative Alu-PCR and we confirmed the… Continue reading Background We previously demonstrated that hsa-miR-520d-5p can convert cancer cells into